Item 1.01. Entry into a Material Definitive Agreement.
On
Under the terms of the Collaboration Agreement, Catalent has agreed to dedicate biomanufacturing space for the manufacture of BridgeBio Products subject to the execution by the Parties of various agreements governing collaboration, development, clinical and/or commercial supply of and with respect to such BridgeBio Products. The Collaboration Agreement sets forth the terms and conditions of the overall relationship between the Parties and the dedication of a specified manufacturing suite at a Catalent facility (the "Dedicated Clean Room Suite") for BridgeBio for a specified period during each calendar year for the term of the Collaboration Agreement and the execution of one or more manufacturing and supply agreements for clinical and commercial supply manufacturing of one or more BridgeBio Products (each such agreement being referred to herein as the "BridgeBio Manufacturing and Supply Agreement"). In consideration for the Dedicated Clean Room Suite, BridgeBio Gene Therapy has agreed to certain minimum purchase obligations. In addition, BridgeBio Gene Therapy shall pay Catalent a one-time fee to reserve the Dedicated Clean Room Suite, which will be applied to the buildout, commissioning, qualification, validation, equipping and exclusive use of the Dedicated Clean Room Suite.
Unless earlier terminated, the Collaboration Agreement will expire upon the
earlier of (i) the latest expiration or termination of the (x) the BridgeBio
Manufacturing and Supply Agreement or (y) any additional supply agreements
negotiated in good faith as outlined in the Collaboration Agreement; and
(ii) five (5) years from the determination by the
The foregoing description of the Collaboration Agreement is not intended to be
complete and is qualified in its entirety by reference to the full text of such
agreement, a copy of which will be filed as an exhibit to the Company's Annual
Report on Form 10-K for the year ended
--------------------------------------------------------------------------------
© Edgar Online, source